TAKTakedaSigning up patients
A Study of Rusfertide in Japanese Adults With Polycythemia Vera
Polycythemia Vera
5Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
- +4.9
2 insiders sold shares within a month
Since Nov 4, 2026 · was worth 5, fading over time
Worry score5
Score over time
- Stage
- Phase 2
- Patients
- 9 (planned)
- Started
- Jul 14, 2026
- Main results expected
- Oct 28, 2027
- Fully finished
- May 17, 2030
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Percentage of Participants Achieving a Response Starting at Week 20 through Week 32
Measured over: Week 20, up to Week 32
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- insider_selling_cluster: base 5, now 4.9, since 2026-11-04, fades (half-life)
Raw record changes
- none yet
Trial ID NCT07648030 · record last updated 2026-10-02 · checked 2026-11-09 15:47 UTC